Evofem Biosciences Inc. Shares Close the Week 25.4% Higher - Weekly Wrap

The company saw its shares close the week 25.4% higher than last week, with trading volume higher than its 30 day average.

Mar 12, 2021 by Kwhen Finance Editors

Evofem Biosciences Inc. Shares Close the Week 25.4% Higher - Weekly Wrap
Evofem Biosciences Inc. shares closed this week 25.4% higher than it did at the end of last week. The stock is currently up 18.7% year-to-date, down 28.0% over the past 12 months, and up 388.9% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%.

Trading Activity

  • Shares traded as high as $3.18 and as low as $2.17 this week.
  • Shares closed 6e+1% below its 52-week high and 5e+1% above its 52-week low.
  • Trading volume this week was 29.7% lower than the 10-day average and 8.8% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was between 30 and 70.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and beats it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Evofem Biosciences Inc.-0.318.7-28.0-59.844.5
Dow Jones Industrial Average0.97.658.0-0.882.1
S&P 500 Index0.15.461.8-0.981.9
Health Care0.21.240.5-4.660.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 93.7%
  • The company's stock price performance over the past 12 months lags the peer average by -2149.2%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Evofem Biosciences Inc.EVFM018.7-28.0-59.844.5
Peer AvgN/A-2.29.61.4-19.145.9
Omeros CorporationOMER-8.837.630.7-17.7131.1
Odonate Therapeutics Inc.ODT00.9-25.3-58.852.5

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: